Department of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Department of Translational Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Int J Mycobacteriol. 2023 Apr-Jun;12(2):162-167. doi: 10.4103/ijmy.ijmy_96_23.
In India, 15%-20% of tuberculosis (TB) cases are categorized as extra-pulmonary TB, and tuberculous pleural effusion (TPE) is the second-most common type after tuberculous lymphadenitis. However, the paucibacillary nature of TPE makes its diagnosis challenging. As a result, relying on empirical anti-TB treatment (ATT) based on clinical diagnosis becomes necessary for achieving the best possible diagnostic outcome. The study aims to determine the diagnostic utility of Xpert Mycobacterium tuberculosis/rifampicin (MTB/RIF) for the detection of TB in TPE in high incidence setting of Central India.
The study enrolled 321 patients who had exudative pleural effusion detected through radiological testing and were suspected of having TB. The medical procedure of thoracentesis was conducted to collect the pleural fluid, which was then subjected to both the Ziehl-Neelsen staining and Xpert MTB/RIF test. The patients who showed improvement after receiving anti-tuberculosis treatment (ATT) were considered the composite reference standard.
The sensitivity of smear microscopy was found to be 10.19%, while that of the Xpert MTB/RIF method was 25.93% when compared to the composite reference standard. The accuracy of clinical diagnosis was measured using receiver operating characteristics based on clinical symptoms, and it was found to be 0.858 (area under the curve).
The study shows that Xpert MTB/RIF has significant value in diagnosing TPE, despite its low sensitivity of 25.93%. Clinical diagnosis based on symptoms was relatively accurate, but relying on symptoms alone is not enough. Using multiple diagnostic tools, including Xpert MTB/RIF, is crucial for accurate diagnosis. Xpert MTB/RIF has excellent specificity and can detect RIF resistance. Its quick results make it useful in situations where a rapid diagnosis is necessary. While it should not be the only diagnostic tool, it has a valuable role in diagnosing TPE.
在印度,15%-20%的结核病(TB)病例被归类为肺外结核病,结核性胸腔积液(TPE)是继结核性淋巴结炎之后第二常见的类型。然而,TPE 的少菌性使其诊断具有挑战性。因此,基于临床诊断的经验性抗结核治疗(ATT)成为获得最佳诊断结果的必要手段。本研究旨在确定 Xpert 分枝杆菌/利福平(MTB/RIF)检测在印度中部高发地区 TPE 中检测 TB 的诊断效用。
本研究纳入了 321 名通过影像学检查发现渗出性胸腔积液并疑似患有 TB 的患者。通过胸腔穿刺术采集胸腔积液,然后对其进行萋-尼氏染色和 Xpert MTB/RIF 检测。根据接受抗结核治疗(ATT)后患者的改善情况,将其视为复合参考标准。
与复合参考标准相比,涂片显微镜的灵敏度为 10.19%,而 Xpert MTB/RIF 方法的灵敏度为 25.93%。根据临床症状基于受试者工作特征曲线评估的临床诊断准确性为 0.858(曲线下面积)。
尽管 Xpert MTB/RIF 的灵敏度为 25.93%,但它对 TPE 的诊断具有重要价值。基于症状的临床诊断相对准确,但仅依赖症状是不够的。使用包括 Xpert MTB/RIF 在内的多种诊断工具对于准确诊断至关重要。Xpert MTB/RIF 具有出色的特异性,可检测利福平耐药性。其快速的检测结果使其在需要快速诊断的情况下非常有用。虽然它不应作为唯一的诊断工具,但它在诊断 TPE 方面具有重要的作用。